In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols Babesia test for samples received on April 20, 2020 at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Be watching for details on an upcoming webinar that will provide you with an overview of implementing this testing.
Check out the Communication page for the complete details by clicking the link: Communications
That’s just one of the reasons that National Blood Donor Month, which has taken place each Jan...
CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinu...
IPFA welcomes Marion Lanteri as Executive Board member, CTS as new member organization
On December 9, 2019, the new CTS Laboratory Information System successfully implemented in Phoe...
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
As an organization dedicated to the safety of the world’s blood and plasma supply, Creative Testing...